{"id":2710,"date":"2020-09-02T13:42:38","date_gmt":"2020-09-02T10:42:38","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=2710"},"modified":"2020-09-02T13:42:38","modified_gmt":"2020-09-02T10:42:38","slug":"ulkemizde-covid-19-hastalarinda-remdesivir-kullanim-olcutleri","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/ulkemizde-covid-19-hastalarinda-remdesivir-kullanim-olcutleri\/","title":{"rendered":"\u00dclkemizde COVID-19 Hastalar\u0131nda Remdesivir Kullan\u0131m \u00d6l\u00e7\u00fctleri"},"content":{"rendered":"<p>T\u0130TCK, COVID-19 tedavisinde, 24 A\u011fustos 2020 tarihli yurtd\u0131\u015f\u0131 ila\u00e7 etkin maddesi listesinde remdesivir kullan\u0131m \u00f6l\u00e7\u00fctlerini tan\u0131mlad\u0131.<\/p>\n<p>Orta\/ileri evre COVID-19 tan\u0131s\u0131 alm\u0131\u015f hastalar, remdesivir kullan\u0131m\u0131 i\u00e7in a\u015fa\u011f\u0131daki kriterlerin t\u00fcm\u00fcn\u00fc kar\u015f\u0131lamal\u0131d\u0131r:<\/p>\n<p><strong>1)<\/strong> 18 ya\u015f ve \u00fczeri erkek veya kad\u0131n (gebe hastalar ve emziren hastalar hari\u00e7) olmas\u0131<\/p>\n<p><strong>2)<\/strong> Temas \u00f6yk\u00fcs\u00fc olan veya uygun klinik yak\u0131nmalar e\u015fli\u011finde PCR ve\/veya kabul edilen di\u011fer serolojik y\u00f6ntemler ile COVID -19 tan\u0131s\u0131 alm\u0131\u015f ve\/veya akci\u011fer BT\u2019de COVID -19 ile uyumlu bulgular\u0131 olan orta\/ileri olgularda remdesivir tedavi karar\u0131 verilmi\u015f olmas\u0131<\/p>\n<p><strong>3)<\/strong> Ate\u015f veya solunum yolu enfeksiyonu bulgular\u0131na ek olarak \u015funlardan en az birinin olmas\u0131:<\/p>\n<p><strong>a)<\/strong> Solunum h\u0131z\u0131 &gt;30\/ dk<\/p>\n<p><strong>b)<\/strong> \u015eiddetli solunum s\u0131k\u0131nt\u0131s\u0131 (dispne, ekstra solunum kaslar\u0131n\u0131n kullan\u0131m\u0131)<\/p>\n<p><strong>c)<\/strong> BT\u2019de akci\u011fer parenkiminin %50 den fazla tutulumu<\/p>\n<p><strong>d)<\/strong> Oda havas\u0131nda spo2 \u2264 %94<\/p>\n<p><strong>4)<\/strong> Tedavi s\u00fcrecinde belirli aral\u0131klarla orofaringeal \u00f6rnek ve ven\u00f6z kan toplanmas\u0131n\u0131 hastan\u0131n ve\/veya yak\u0131n\u0131n\u0131n kabul etmi\u015f olmas\u0131<\/p>\n<p><strong>5)<\/strong> Multiorgan yetmezli\u011fi olmamas\u0131<\/p>\n<p><strong>6)<\/strong> Septik \u015fok i\u00e7in vazopres\u00f6r kullan\u0131lmamas\u0131<\/p>\n<p><strong>7)<\/strong> ALT &lt; 5 x normal \u00fcst s\u0131n\u0131r\u0131 (ULN)<\/p>\n<p><strong>8)<\/strong> EGRF &gt; 30 ml\/dak<\/p>\n<p><strong>9)<\/strong> Favipiravir kullanmam\u0131\u015f olmak<\/p>\n<p><a href=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2020\/09\/YurtDEtkinMaddeListesi24.08.2020TarihindentibarenGeerliOlanListe_5825119e-abe9-4fba-aba3-d0b8dbfd9d8e.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Listenin Tamam\u0131 \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\u0130TCK, COVID-19 tedavisinde, 24 A\u011fustos 2020 tarihli yurtd\u0131\u015f\u0131 ila\u00e7 etkin maddesi listesinde remdesivir kullan\u0131m \u00f6l\u00e7\u00fctlerini tan\u0131mlad\u0131. Orta\/ileri evre COVID-19 tan\u0131s\u0131 alm\u0131\u015f hastalar, remdesivir kullan\u0131m\u0131 i\u00e7in a\u015fa\u011f\u0131daki kriterlerin t\u00fcm\u00fcn\u00fc kar\u015f\u0131lamal\u0131d\u0131r: 1) 18 ya\u015f ve \u00fczeri erkek veya kad\u0131n (gebe hastalar ve emziren hastalar hari\u00e7) olmas\u0131 2) Temas \u00f6yk\u00fcs\u00fc olan veya uygun klinik yak\u0131nmalar e\u015fli\u011finde PCR ve\/veya kabul edilen di\u011fer serolojik y\u00f6ntemler ile COVID -19 tan\u0131s\u0131 alm\u0131\u015f ve\/veya akci\u011fer BT\u2019de COVID -19 ile uyumlu bulgular\u0131 olan orta\/ileri olgularda remdesivir tedavi karar\u0131 verilmi\u015f olmas\u0131 3) Ate\u015f veya solunum yolu enfeksiyonu bulgular\u0131na ek olarak \u015funlardan en az birinin olmas\u0131: a) Solunum h\u0131z\u0131 &gt;30\/ dk [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":2711,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/2710"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=2710"}],"version-history":[{"count":1,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/2710\/revisions"}],"predecessor-version":[{"id":2712,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/2710\/revisions\/2712"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/2711"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=2710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=2710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=2710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}